Clinical Trial Update: TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TNRF:Fc for eye inflammation in juvenile idiopathic arthritis and uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Uveitis

Drugs mentioned

• TNRF:Fc (TNF receptor-Fc fusion protein)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Juvenile Rheumatoid Arthritis, Uveitis | Phase 2 | Status: COMPLETED